India's Bharat Biotech says vaccine 93.4% effective against severe COVID-19
Published
Phase-III trials of a vaccine made by India's Bharat Biotech showed it was 93.4% effective against severe symptomatic COVID-19, the firm...
Full ArticlePublished
Phase-III trials of a vaccine made by India's Bharat Biotech showed it was 93.4% effective against severe symptomatic COVID-19, the firm...
Full ArticleBy R Ramakumar*
In May 2021, the Supreme Court of India remarked that the country’s policy of charging those aged..
India's Bharat Biotech says late-stage trials showed Covaxin was 93.4% effective against severe symptomatic COVID. Meanwhile,..